Home Tags AKRX

Tag: AKRX

There Is Reason to Like Akorn, Inc. (AKRX) and Eldorado Gold...

For Akorn, Inc. (NASDAQ:AKRX) Thursday was another day of weak-handed selling, with the low volume day punctuated by a decline from previous close. Trading...

Guru Analysis Of Akorn, Inc. (AKRX)

Akorn, Inc. (NASDAQ:AKRX) enjoyed a 15.61% run-up in share price since hitting record low of $3.14. The stock managed -2.94% fall and now stands...

Analyzing Stocks On Analyst Opinion: Akorn, Inc. (AKRX), FibroGen, Inc. (FGEN)

Akorn, Inc. (NASDAQ:AKRX) notched a 2.59% intraday gain moving at $3.57. When the opening bell rang, the price was $3.56. The number of shares...

Why New Institutional Money Is Coming and What This Means for...

Akorn, Inc. (NASDAQ:AKRX) is on recovery track with 25.8% gain from a 1-year low price of $3.14. The company added 6.76% to attain the...

Should Traders Get Out Of Akorn, Inc. (AKRX), PPG Industries, Inc....

For Akorn, Inc. (NASDAQ:AKRX) Friday was another day of strong-handed buying, with the low volume day punctuated by a rise from previous close. Trading...

Are Mylan N.V. (MYL) And Akorn, Inc. (AKRX) Near Their Buy...

Mylan N.V. (NASDAQ:MYL) trading capacity remained 4.71 million shares during the last session. However, the volume average of the last three months is 5.41...

Does Current Valuations Warrant A Buy or Sell? – Akorn, Inc....

Here's what's interesting to note about Akorn, Inc. (NASDAQ:AKRX) right now: Its price-to-sales ratio of 4.02, is expensive relative to the Major Pharmaceuticals universe...

Akorn, Inc. (AKRX) Garnering Institutional Investor Support?

Akorn, Inc. (NASDAQ:AKRX) has made a 7.45% comeback from a 12-month low price of $3.15. It was seen -1.74% lower, changing the price to...

Analysts Give These Stocks Mix Nod: Aramark (ARMK), Akorn, Inc. (AKRX)

Aramark (NYSE:ARMK) recorded a trading volume of 3.39 million shares, below its 90-day volume average of 3.58 million shares. The stock kicked off the...

The Value Trap: Akorn, Inc. (AKRX), Zoetis Inc. (ZTS)

Akorn, Inc. (NASDAQ:AKRX) is offering a bear trap with a P/S ratio at 4.02. The broad Major Pharmaceuticals industry has an average P/S ratio...